drugset / Trial / NCT06186583
A Mass Balance Study of [14C]ABSK021
NaSingle-groupOpen-labelTreatment
Summary
This study is a single-site, open-label, single-cohort, single-dose study to assess the absorption, metabolism, and excretion profile of \[14C\] ABSK021 in healthy adult male subjects. The study plans to enroll 6 to 10 healthy male subjects to ensure at least 6 evaluable subjects.
Timeline
- Start
- 2023-12-13
- Primary completion
- 2024-05-30
- Completion
- 2024-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pimicotinib | Small molecule | 50 mg | Oral |
Indications
No indication recorded.